Corbus Pharmaceuticals Holdings, Inc.(CRBP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRBP Corbus Pharmaceuticals Holdings, Inc.

盘后交易 02-04 17:43:47 EST

8.01

-0.09

-1.11%

盘后8.18

+0.17+2.12%

17:23 EST

最高8.33	最低7.75	成交量11.12万
今开8.10	昨收8.10	日振幅7.16%
总市值1.41亿	流通市值9,842万	总股本1,755万
成交额88.44万	换手率0.90%	流通股本1,229万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRBP","market":"US","secType":"STK","nameCN":"Corbus Pharmaceuticals Holdings, Inc.","latestPrice":8.01,"timestamp":1770238800000,"preClose":8.1,"halted":0,"volume":111166,"hourTrading":{"tag":"盘后","latestPrice":8.18,"preClose":8.01,"latestTime":"17:23 EST","volume":2048,"amount":16485.052416,"timestamp":1770243780137,"change":0.17,"changeRate":0.021223,"amplitude":0.022472},"delay":0,"changeRate":-0.011111111111111094,"floatShares":12286700,"shares":17553037,"eps":-5.517979,"marketStatus":"盘后交易","change":-0.09,"latestTime":"02-04 17:43:47 EST","open":8.1,"high":8.33,"low":7.75,"amount":884417.1307839999,"amplitude":0.071605,"askPrice":8.36,"askSize":500,"bidPrice":8.17,"bidSize":45,"shortable":3,"etf":0,"ttmEps":-5.517979,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770253200000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":8.1,"postHourTrading":{"tag":"盘后","latestPrice":8.18,"preClose":8.01,"latestTime":"17:23 EST","volume":2048,"amount":16485.052416,"timestamp":1770243780137,"change":0.17,"changeRate":0.021223,"amplitude":0.022472},"volumeRatio":0.858427,"impliedVol":0.1686,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/CRBP","defaultTab":"news","newsList":[{"id":"1115509709","title":"Corbus Pharmaceuticals Holdings, Inc. - 启动12周剂量寻找研究，预计2026年夏季完成","url":"https://stock-news.laohu8.com/highlight/detail?id=1115509709","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115509709?lang=zh_cn&edition=full","pubTime":"2025-12-11 20:03","pubTimestamp":1765454627,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals Holdings, Inc. - 启动12周剂量寻找研究，预计2026年夏季完成","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP","BK4139"],"gpt_icon":0},{"id":"1124429329","title":"Corbus Pharmaceuticals公布口服CB1反向激动剂Crb-913用于肥胖治疗的1a期研究结果，显示出良好的安全性和减重初步证据","url":"https://stock-news.laohu8.com/highlight/detail?id=1124429329","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124429329?lang=zh_cn&edition=full","pubTime":"2025-12-11 20:02","pubTimestamp":1765454571,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals公布口服CB1反向激动剂Crb-913用于肥胖治疗的1a期研究结果，显示出良好的安全性和减重初步证据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRBP"],"gpt_icon":0},{"id":"1137625300","title":"Corbus Pharmaceuticals将在2025年12月11日星期四发布口服CB1反向激动剂Crb-913治疗肥胖的1a期研究结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1137625300","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137625300?lang=zh_cn&edition=full","pubTime":"2025-12-11 05:03","pubTimestamp":1765400593,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals将在2025年12月11日星期四发布口服CB1反向激动剂Crb-913治疗肥胖的1a期研究结果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRBP"],"gpt_icon":0},{"id":"2588096476","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 早盘股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588096476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588096476?lang=zh_cn&edition=full","pubTime":"2025-12-03 00:20","pubTimestamp":1764692447,"startTime":"0","endTime":"0","summary":"北京时间2025年12月03日00时20分，Corbus Pharmaceuticals Holdings, Inc.股票出现波动，股价快速跳水5.30%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Corbus Pharmaceuticals Holdings, Inc.公司简介：Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精密肿瘤公司，致力于通过将科学方法引入了解的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203002047a4c8750c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203002047a4c8750c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBP"],"gpt_icon":0},{"id":"2584791012","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584791012","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584791012?lang=zh_cn&edition=full","pubTime":"2025-11-18 23:25","pubTimestamp":1763479504,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日23时25分，Corbus Pharmaceuticals Holdings, Inc.股票出现波动，股价急速拉升5.16%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Corbus Pharmaceuticals Holdings, Inc.公司简介：Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精密肿瘤公司，致力于通过将科学方法引入了解的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118232505950c782f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118232505950c782f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBP","BK4139"],"gpt_icon":0},{"id":"2579040829","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 早盘股价大涨5.29%报17.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579040829","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579040829?lang=zh_cn&edition=full","pubTime":"2025-10-28 22:25","pubTimestamp":1761661540,"startTime":"0","endTime":"0","summary":"北京时间2025年10月28日22时25分，Corbus Pharmaceuticals Holdings, Inc.股票出现波动，股价急速拉升5.29%。截至发稿，该股报17.91美元/股，成交量3.2369万股，换手率0.26%，振幅5.70%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Corbus Pharmaceuticals Holdings, Inc.公司简介：Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精密肿瘤公司，致力于通过将科学方法引入了解的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510282225409746dbe7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202510282225409746dbe7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBP","BK4139"],"gpt_icon":0},{"id":"1109814401","title":"Corbus Pharmaceuticals股价盘前上涨4.8%，FDA授予公司头颈部癌症抗体药物快速通道地位","url":"https://stock-news.laohu8.com/highlight/detail?id=1109814401","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109814401?lang=zh_cn&edition=full","pubTime":"2025-09-16 20:18","pubTimestamp":1758025096,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals股价在盘前交易中上涨4.8%，此前美国食品药品监督管理局(FDA)授予该公司针对头颈部癌症的抗体药物联合疗法快速通道地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP","BK4139"],"gpt_icon":0},{"id":"1185646956","title":"FDA为Corbus Pharmaceuticals的Nectin-4靶向ADC药物CRB-701治疗头颈部鳞状细胞癌授予快速通道资格","url":"https://stock-news.laohu8.com/highlight/detail?id=1185646956","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185646956?lang=zh_cn&edition=full","pubTime":"2025-09-16 20:00","pubTimestamp":1758024023,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局(FDA)已为Corbus Pharmaceuticals的Nectin-4靶向抗体药物偶联物(ADC)CRB-701授予快速通道资格，用于治疗头颈部鳞状细胞癌。\n这一快速通道资格的获得，将有助于加速CRB-701的研发进程，为头颈部鳞状细胞癌患者提供新的治疗选择。该药物专门针对Nectin-4蛋白，通过抗体药物偶联技术，有望为这类癌症患者带来更有效的治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP","BK4139"],"gpt_icon":0},{"id":"2558220681","title":"Corbus Pharmaceuticals Holdings, Inc.2025财年第二财季实现净利润-17.66百万美元，同比减少76.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558220681","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558220681?lang=zh_cn&edition=full","pubTime":"2025-08-11 00:01","pubTimestamp":1754841689,"startTime":"0","endTime":"0","summary":"8月11日，Corbus Pharmaceuticals Holdings, Inc.公布财报，公告显示公司2025财年第二财季净利润为-17.66百万美元，同比减少76.60%；其中营业收入为0.00美元，每股基本收益为-1.44美元。机构评级：截至2025年8月11日，当前有9家机构对Corbus Pharmaceuticals Holdings, Inc.目标价做出预测，其中目标均价为42.22美元，其中最低目标价为28.00美元，最高目标价为55.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000329a4805755&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000329a4805755&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBP"],"gpt_icon":0},{"id":"2558085579","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 大幅下挫5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558085579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558085579?lang=zh_cn&edition=full","pubTime":"2025-08-09 01:12","pubTimestamp":1754673131,"startTime":"0","endTime":"0","summary":"北京时间2025年08月09日01时12分，Corbus Pharmaceuticals Holdings, Inc.股票出现波动，股价大幅下跌5.33%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.60%。Corbus Pharmaceuticals Holdings, Inc.公司简介：Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精密肿瘤公司，致力于通过将科学方法引入了解的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809011211973c3dad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809011211973c3dad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBP"],"gpt_icon":0},{"id":"1180008347","title":"Corbus制药公司第四季度每股收益$(0.78)优于预期的$(1.20)","url":"https://stock-news.laohu8.com/highlight/detail?id=1180008347","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180008347?lang=zh_cn&edition=full","pubTime":"2025-03-11 21:00","pubTimestamp":1741698029,"startTime":"0","endTime":"0","summary":"Corbus制药公司第四季度每股收益$(0.78)优于预期的$(1.20)以上内容来自Benzinga Earnings专栏，原文如下：Corbus Pharmaceuticals Q4 EPS $(0.78) Beats $(1.20) Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Corbus制药公司第四季度每股收益$(0.78)优于预期的$(1.20)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"gpt_icon":0},{"id":"2516637872","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637872","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516637872?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:03","pubTimestamp":1741014224,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时03分，Corbus Pharmaceuticals Holdings, Inc.股票出现异动，股价急速下跌5.10%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。Corbus Pharmaceuticals Holdings, Inc.公司简介：Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司，致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230345a25d49c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230345a25d49c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBP"],"gpt_icon":0},{"id":"2514320289","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 股价大涨7.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514320289?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753065,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Corbus Pharmaceuticals Holdings, Inc.股票出现波动，股价大幅上涨7.50%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Corbus Pharmaceuticals Holdings, Inc.公司简介：Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司，致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282231059896796e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502282231059896796e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBP"],"gpt_icon":0},{"id":"2513372082","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 快速下跌5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513372082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513372082?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:54","pubTimestamp":1740408851,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时54分，Corbus Pharmaceuticals Holdings, Inc.股票出现异动，股价急速下跌5.26%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Corbus Pharmaceuticals Holdings, Inc.公司简介：Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司，致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225411962e9e81&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224225411962e9e81&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBP","BK4139"],"gpt_icon":0},{"id":"2512439953","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 下午盘快速下挫5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512439953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512439953?lang=zh_cn&edition=full","pubTime":"2025-02-20 04:07","pubTimestamp":1739995653,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日04时07分，Corbus Pharmaceuticals Holdings, Inc.股票出现波动，股价快速跳水5.12%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。Corbus Pharmaceuticals Holdings, Inc.公司简介：Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司，致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200407349629027c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502200407349629027c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBP","BK4139"],"gpt_icon":0},{"id":"2511577852","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511577852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511577852?lang=zh_cn&edition=full","pubTime":"2025-02-14 04:55","pubTimestamp":1739480140,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日04时55分，Corbus Pharmaceuticals Holdings, Inc.股票出现异动，股价急速上涨5.10%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.11%。Corbus Pharmaceuticals Holdings, Inc.公司简介：Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司，致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214045541a244f671&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214045541a244f671&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBP","BK4139"],"gpt_icon":0},{"id":"2510338178","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 早盘股价大跌5.11%报9.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510338178","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510338178?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:04","pubTimestamp":1739286285,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时04分，Corbus Pharmaceuticals Holdings, Inc.股票出现异动，股价急速跳水5.11%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为1.36%。Corbus Pharmaceuticals Holdings, Inc.公司简介：Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司，致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112304459881c3a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112304459881c3a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBP"],"gpt_icon":0},{"id":"2510559258","title":"HC Wainwright & Co.：重申Corbus Pharmaceuticals(CRBP.US)评级，由买入调整至买入评级, 目标价由80.00美元调整至75.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510559258","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510559258?lang=zh_cn&edition=full","pubTime":"2025-02-10 19:54","pubTimestamp":1739188451,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Corbus Pharmaceuticals(CRBP.US)评级，由买入调整至买入评级, 目标价由80.00美元调整至75.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/10195448056207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CRBP"],"gpt_icon":0},{"id":"2509728306","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 急速下跌5.09%报10.73美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509728306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509728306?lang=zh_cn&edition=full","pubTime":"2025-02-07 23:44","pubTimestamp":1738943098,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日23时44分，Corbus Pharmaceuticals Holdings, Inc.股票出现异动，股价大幅下挫5.09%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。Corbus Pharmaceuticals Holdings, Inc.公司简介：Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司，致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207234458987dbb21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207234458987dbb21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CRBP"],"gpt_icon":0},{"id":"2509235773","title":"Corbus Pharmaceuticals Holdings, Inc.盘中异动 大幅上涨5.18%报10.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509235773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509235773?lang=zh_cn&edition=full","pubTime":"2025-02-06 00:23","pubTimestamp":1738772609,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日00时23分，Corbus Pharmaceuticals Holdings, Inc.股票出现波动，股价快速上涨5.18%。Corbus Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.42%。Corbus Pharmaceuticals Holdings, Inc.公司简介：Corbus Pharmaceuticals Holdings Inc 是一家拥有多元化产品组合的精准肿瘤学公司，致力于通过将科学方法引入人们熟知的生物途径来帮助人们战胜严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206002329987b8f3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206002329987b8f3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CRBP","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.corbuspharma.com","stockEarnings":[{"period":"1week","weight":-0.1474},{"period":"1month","weight":0.0292},{"period":"3month","weight":-0.2569},{"period":"6month","weight":-0.1},{"period":"1year","weight":-0.1483},{"period":"ytd","weight":-0.0049}],"compareEarnings":[{"period":"1week","weight":-0.0086},{"period":"1month","weight":0.0093},{"period":"3month","weight":0.0176},{"period":"6month","weight":0.0906},{"period":"1year","weight":0.1535},{"period":"ytd","weight":0.0112}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Corbus Pharmaceuticals Holdings, Inc.于2009年4月24日根据特拉华州法律注册成立。Corbus是一家精准肿瘤学公司，拥有多元化的产品组合，致力于通过将创新的科学方法引入已被广泛理解的生物途径，帮助人们战胜严重疾病。该公司的管线由两种针对实体瘤的实验药物组成：CRB-701，一种下一代抗体药物偶联物，靶向Nectin-4在癌细胞上的表达以释放细胞毒性有效载荷，CRB-601，一种抗整合素单克隆抗体，可阻断癌细胞上表达的TGFβ的激活。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.363358},{"month":2,"riseRate":0.272727,"avgChangeRate":-0.053844},{"month":3,"riseRate":0.6,"avgChangeRate":0.208224},{"month":4,"riseRate":0.5,"avgChangeRate":0.045906},{"month":5,"riseRate":0.636364,"avgChangeRate":0.079186},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.065346},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.050382},{"month":8,"riseRate":0.636364,"avgChangeRate":0.095672},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.086452},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.124298},{"month":11,"riseRate":0.727273,"avgChangeRate":0.130055},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.132264}],"exchange":"NASDAQ","name":"Corbus Pharmaceuticals Holdings, Inc.","nameEN":"Corbus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Corbus Pharmaceuticals Holdings, Inc.(CRBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Corbus Pharmaceuticals Holdings, Inc.(CRBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Corbus Pharmaceuticals Holdings, Inc.,CRBP,Corbus Pharmaceuticals Holdings, Inc.股票,Corbus Pharmaceuticals Holdings, Inc.股票老虎,Corbus Pharmaceuticals Holdings, Inc.股票老虎国际,Corbus Pharmaceuticals Holdings, Inc.行情,Corbus Pharmaceuticals Holdings, Inc.股票行情,Corbus Pharmaceuticals Holdings, Inc.股价,Corbus Pharmaceuticals Holdings, Inc.股市,Corbus Pharmaceuticals Holdings, Inc.股票价格,Corbus Pharmaceuticals Holdings, Inc.股票交易,Corbus Pharmaceuticals Holdings, Inc.股票购买,Corbus Pharmaceuticals Holdings, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Corbus Pharmaceuticals Holdings, Inc.(CRBP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Corbus Pharmaceuticals Holdings, Inc.(CRBP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}